Page last updated: 2024-08-17

reserpine and dihydroergocristine

reserpine has been researched along with dihydroergocristine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K	1
Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K	1
Blazek, M; Cepelák, V; Cerný, J; Cícha, Z; Kokaisl, V; Koznarová, M; Mádle, A; Mayer, O; Mazanec, J; Moses, K; Munzarová, A; Niebauer, R; Vácha, J	1

Trials

1 trial(s) available for reserpine and dihydroergocristine

Article	Year
[Crystepin CH. A multi-centre trial of an antihypertensive drug (author's transl)]. Casopis lekaru ceskych, 1981, Aug-27, Volume: 120, Issue:34 Topics: Adult; Aged; Antihypertensive Agents; Chlorthalidone; Clinical Trials as Topic; Clopamide; Dihydroergocristine; Dihydroergotoxine; Drug Combinations; Female; Humans; Hypertension; Isoindoles; Male; Middle Aged; Reserpine	1981

Other Studies

2 other study(ies) available for reserpine and dihydroergocristine

Article	Year
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein. Molecular pharmacology, 2002, Volume: 61, Issue:5 Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine	2002
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1 Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine	2002

Article

Year

Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.

Molecular pharmacology, 2002, Volume: 61, Issue:5

Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine

2002

Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.

The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine

2002